GlassScriptPhysician profile
Donald Upton
NPI 1831320225
$13,522.11
in general payments reported to CMS, 2019-2025
51 companies · $4,196 in 2025
The $4,196 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,153 · 2022: $2,371 · 2023: $2,440 · 2024: $2,362 · 2025: $4,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,668 · Travel and Lodging: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,667.71 |
| Travel and Lodging | $331.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,390.73 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,364.29 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,109.50 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $916.29 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $823.24 | 2021-2025 | |
| Medtronic, INC. | $764.44 | 2025 | Minimed 780g |
| Lilly USA, LLC | $671.87 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Janssen Pharmaceuticals, INC | $502.84 | 2021-2024 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $470.60 | 2022-2025 | Rexulti |
| Astellas Pharma US INC | $449.17 | 2021-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $403.14 | 2021-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $390.32 | 2021-2025 | |
| Amgen INC. | $366.62 | 2021-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.86 | 2021-2025 | Jardiance |
| Corium, LLC | $296.05 | 2022-2024 | Azstarys |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Upton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.